Clinical Trial Update: Korean Post-marketing Surveillance for Kombiglyze XR®

View source ↗

Summary

Completed results of a Korean post-marketing surveillance study of Kombiglyze XR (saxagliptin/metformin) in adults with Type 2 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Kombiglyze XR (Saxagliptin/metformin XR)

Snippet

Sponsor: AstraZeneca | Conditions: Diabetes Mellitus, Type 2 | Status: COMPLETED